News
ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD ) recently released a strong earnings report, and the market responded ...
Second Quarter 2025 Results Key Financial Results Revenue: US$264.6m (up ...
15h
Stockhead on MSNMorgans spotlights nine healthcare stocks with upcoming catalysts after “upbeat” Bioshares Biotech Summit
Morgan's Scott Power highlights nine ASX healthcare companies from the 2025 Bioshares Biotech Summit with catalysts over next ...
Detailed price information for Avadel Pharmaceuticals Plc ADR (AVDL-Q) from The Globe and Mail including charting and trades.
Detailed price information for Amn Healthcare Services Inc (AMN-N) from The Globe and Mail including charting and trades.
Living within 3 miles of a golf course or using a vulnerable tap water source is associated with an increased risk for Parkinson Disease.
Shares little changed from Wednesday’s record; ASX hammered on monopoly chatter, costs hit; Domain to exit sharemarket after ...
Ryan Reynolds had a rocky relationship with his late father, but one sweet act toward the end of his dad's life has given the ...
Find the latest information on ACADIA Pharmaceuticals Inc. Common Stock (ACAD) insider activity and insider shares traded to make sound investments with Nasdaq.com.
1d
TipRanks on MSNStoke Therapeutics Advances RNA Medicine with Strong Q2 Results
Stoke Therapeutics ( ($STOK) ) has released its Q2 earnings. Here is a breakdown of the information Stoke Therapeutics presented to its investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results